BVRS-GamVac-Combi
- Generic Name
- BVRS-GamVac-Combi
Study of Safety and Immunogenicity of BVRS-GamVac-Combi
Phase 1
- Conditions
- MERSMERS (Middle East Respiratory Syndrome)
- Interventions
- Other: placebo
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 268
- Registration Number
- NCT04128059
- Locations
- 🇷🇺
ECO-Safety, Sankt-Peterburg, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath